Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,319
Sort by:
2017 Australia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Austria Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Belgium Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Bulgaria Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Cyprus Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Denmark Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Estonia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Finland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Greece Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Hungary Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Iceland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Ireland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Latvia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Lithuania Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Malta Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Netherlands Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Norway Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Poland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Portugal Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Romania Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Slovakia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Slovenia Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Sweden Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Switzerland Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
US$ 2,475.00
... and suggests specific product and marketing opportunities facing suppliers. Hematology Tests Analyzed in the Report CBC + 5-Part Differential, Manual Differential ... Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils. Flow Cytometry Tests Analyzed in the Report Cell Surface Markers ( ...
March 2017
225 pages
2017 Australia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Austria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Belgium Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Bulgaria Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Cyprus Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Czech Republic Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
March 2017
1120 pages
2017 Denmark Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Estonia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Finland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Greece Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Hungary Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Iceland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Ireland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Latvia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Lithuania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Malta Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Netherlands Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Norway Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Poland Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Portugal Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Romania Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages
2017 Slovakia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
US$ 3,825.00
... and consumable suppliers. Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating ...
March 2017
1120 pages